Exploring the Connectivity of Neurodegenerative Diseases: Microglia as the Center

Yan Wang1,2,3,4, Limei Cui2,3,4, He Zhao1,2,3,4

  • 1The Second Medical College, Binzhou Medical University, Yantai, Shandong, People's Republic of China.

PubMed

Insights

Reducing microglia activity can curb degenerative diseases. This review explores microglia

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Degenerative diseases pose significant health and social challenges.
  • Microglia, the central nervous system's immune cells, play a crucial role in disease pathogenesis.
  • Understanding microglia mechanisms is key to developing effective treatments.

Purpose of the Study:

  • To review the mechanisms of microglia in various degenerative diseases.
  • To examine the impact of microglia inhibitors and activators.
  • To highlight microglia's dual role in inflammation and disease progression.

Main Methods:

  • Literature review of studies on microglia in neurodegenerative diseases, age-related hearing loss, Alzheimer's disease, Parkinson's disease, and peripheral nervous system disorders.
  • Analysis of research on microglia modulators like PLX3397/PLX5622 and lipopolysaccharide.

Main Results:

  • Microglia are implicated in the pathogenesis of diverse degenerative conditions.
  • Inhibiting microglia (e.g., with PLX3397/PLX5622) shows potential in curbing disease genesis and progression.
  • Microglia exhibit both anti-inflammatory and pro-inflammatory functions, critical in central and peripheral diseases.

Conclusions:

  • Modulating microglia activity, particularly reducing their detrimental effects, offers a promising therapeutic strategy for degenerative diseases.
  • Targeting microglial cells presents a viable avenue for future treatments, despite their complex nature.